ADVB
Advanced Biomed Inc. Common Stock
NASDAQ: ADVB · HEALTHCARE · DIAGNOSTICS & RESEARCH
$5.30
+0.00% today
Updated 2026-04-29
Market cap
$7.23M
P/E ratio
1.51
P/S ratio
—
EPS (TTM)
$3.52
Dividend yield
—
52W range
$4 – $49
Volume
0.7M
Advanced Biomed Inc. Common Stock (ADVB) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | $1.01M | $6.71M | $4.60M | $4.46M | $6.51B |
| Cash & equivalents | $65922.00 | $4.78M | $2.62M | $2.61M | $2.90B |
| Current assets | $913497.00 | $5.01M | $2.79M | $3.05M | $6.03B |
| Total liabilities | $30131.00 | $3.22M | $3.29M | $2.80M | $3.03B |
| Current liabilities | $28350.00 | $2.99M | $3.28M | $2.73M | $2.89B |
| Long-term debt | — | — | — | — | — |
| Shareholder equity | $976242.00 | $3.49M | $1.31M | $1.66M | $3.48B |
| Retained earnings | $-5.43M | $-9.46M | $-13.19M | $-15.97M | $-19.23B |
| Accounts receivable | $419.00 | $162518.00 | $4814.00 | $6324.00 | $7956.00 |
| Inventory | — | — | — | $-6324.00 | — |
| Goodwill | — | — | — | — | — |